JV

Jacky Vonderscher

CEO

ENYO Pharma

Lyon, Auvergne-Rhone-Alpes


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
ENYO Pharma
Industry
research
Employees
35.0
Seniority
C suite
Annual Revenue
19000000.0
Total Funding
116210636.0
Latest Funding
Series C

Technologies

Outlook Microsoft Office 365 Google Tag Manager WordPress.org Nginx Mobile Friendly Google Analytics AI

Keywords

enterprise software fashion health care information technology health care software information technology biotechnology research therapeutics biopharmaceutical clinical-stage kidney function impaired kidney function fibrolytic anti-inflammatory vonafexor small molecule alport syndrome chronic kidney disease ckd phase 2 clinical trial nash mash drug discovery platform treatment development rare kidney diseases oral administration fda clearance clinical studies pipeline drug candidates targeted therapies biotech clinical trials renal function liver diseases chronic hepatitis b chronic hepatitis d fibrosis molecular biology nephrology patient outcomes diagnostic tools disease management scientific research biomimetism drug profiles preclinical studies differentiated therapy biotech innovation healthcare investment clinical research treatment options metabolic diseases enterprises computer software information technology & services b2b health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans